EXCALIARD PHARMACEUTICALS
Excaliard is a newly formed, venture capital-funded biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and other fibrotic diseases.
EXCALIARD PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2006-01-01
Address:
Carlsbad, California, United States
Country:
United States
Website Url:
http://www.excaliard.com
Status:
Closed
Contact:
760-431-1850
Email Addresses:
[email protected]
Total Funding:
15.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins
Similar Organizations
Founder
Investors List
Alta Partners
Alta Partners investment in Series A - Excaliard Pharmaceuticals
RiverVest
RiverVest investment in Series A - Excaliard Pharmaceuticals
ProQuest Investments
ProQuest Investments investment in Series A - Excaliard Pharmaceuticals
Official Site Inspections
http://www.excaliard.com
- Host name: 78.40.8.135
- IP address: 78.40.8.135
- Location: France
- Latitude: 48.8582
- Longitude: 2.3387
- Timezone: Europe/Paris
More informations about "Excaliard Pharmaceuticals"
Excaliard Pharmaceuticals - Crunchbase Company Profile & Funding
Organization. Excaliard Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Excaliard is a biotechnology …See details»
Excaliard Pharmaceuticals Company Profile | Management and
Excaliard Pharmaceuticals, Inc. is a biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the amelioration of skin …See details»
Pfizer to Acquire Excaliard Pharmaceuticals
Nov 21, 2011 Excaliard Pharmaceuticals, Inc. is a biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative drugs for the …See details»
Excaliard Pharmaceuticals - Company Profile & Staff Directory
Excaliard is a newly formed, venture capital-funded biotechnology company focused on the development and commercialization of antisense drugs for the local treatment of scarring and …See details»
Pfizer Completes Acquisition of Excaliard
(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company …See details»
Excaliard Pharmaceuticals - Overview, News & Similar companies ...
Who is Excaliard Pharmaceuticals. Excaliard Pharmaceuticals, Inc. is a biotechnology company founded in 2007 focused on the development and commercialization of novel and innovative …See details»
Pfizer acquires Excaliard Pharmaceuticals - 2011-11-22 - Crunchbase
Nov 22, 2011 Excaliard Pharmaceuticals Excaliard is a biotechnology company developing antisense drugs for the local treatment of scarring and other fibrotic diseases. Acquiring …See details»
Excaliard Pharmaceuticals - Company Profile - Tracxn
Sep 7, 2024 Excaliard Pharmaceuticals - Develops drugs for the local treatment of scarring and skin fibrotic diseases. Acquired by Pfizer. Raised a total funding of $15.5M over 1 round from 4 …See details»
Organization | Excaliard Pharmaceuticals
Excaliard Pharmaceuticals Report issue For profit Founded: Carlsbad CA United States (2006)See details»
Excaliard Pharmaceuticals, Inc.: Drug pipelines, Patents, Clinical ...
Jun 18, 2023 Explore Excaliard Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, Drug:EXC-001.See details»
Pfizer Inc. : Pfizer Completes Acquisition of Excaliard
Dec 2, 2011 Pfizer Inc. announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing …See details»
Pfizer Completes Acquisition of Excaliard
Acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, more commonly referred …See details»
Excaliard Pharmaceuticals - PitchBook
Excaliard Pharmaceuticals General Information Description. Developer of targeted therapeutics designed to treat dermatological disorders. The company's targeted therapeutics offer …See details»
Pfizer Completes Acquisition of Excaliard
Dec 4, 2011 "Acquiring Excaliard allows us to continue the development of its lead compound EXC 001 to potentially fill a gap and bring a novel new treatment to patients." Nicholas Dean, …See details»
Pfizer To Acquire Excaliard Pharmaceuticals - - - Lead Program …
Excaliard’s lead product, EXC 001, an antisense oligonucleotide in phase 2, is designed to interrupt the process of fibrosis by ... Since that time, using a virtual organization and …See details»
Pfizer acquires Excaliard Pharmaceuticals - Pharmaceutical …
Dec 4, 2011 Pfizer has completed the acquisition of Excaliard Pharmaceuticals, a US biopharma company focused on developing drugs for the treatment of skin fibrosis. The acquisition will …See details»
Pfizer To Acquire Excaliard Pharmaceuticals | Fierce Biotech
Nov 22, 2011 Pfizer To Acquire Excaliard Pharmaceuticals By Business Wire 11/22/11 - 07:30 AM EST Pfizer Inc. ... Since that time, using a virtual organization and maximum outsourcing, …See details»
Pfizer Completes Acquisition of Excaliard | Fierce Pharma
Dec 2, 2011 NEW YORK--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned …See details»
Pfizer to buy Excaliard Pharmaceuticals - Pharmaceutical Technology
Nov 24, 2011 Pfizer has entered into a definitive agreement to acquire Excaliard Pharmaceuticals, gaining access to EXC 001, a skin scarring treatment. Co-developed by …See details»
Pfizer enters agreement to buy Excaliard Pharma
Excaliard’s lead product, EXC 001, an antisense oligonucleotide in phase 2, is designed to interrupt the process of fibrosis by inhibiting expression of connective tissue growth factor …See details»